129 related articles for article (PubMed ID: 9370045)
1. Use of radioactive phosphorus in haematology.
Roberts BE; Smith AH
Blood Rev; 1997 Sep; 11(3):146-53. PubMed ID: 9370045
[TBL] [Abstract][Full Text] [Related]
2. Treatment of the myeloproliferative disorders with 32P.
Berlin NI
Eur J Haematol; 2000 Jul; 65(1):1-7. PubMed ID: 10914933
[TBL] [Abstract][Full Text] [Related]
3. Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P).
Randi ML; Fabris F; Varotto L; Rossi C; Macri C; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):461-7. PubMed ID: 1703118
[TBL] [Abstract][Full Text] [Related]
4. Observations on polycythemia vera turning into acute or chronic granulocytic leukemia during treatment with radioactive phosphorus 32P.
Krańik W
Pol Med Sci Hist Bull (1973); 1975; 15(4):447-52. PubMed ID: 1063385
[TBL] [Abstract][Full Text] [Related]
5. The incidence of leukaemia in patients with polycythaemia vera treated by radioactive phosphorus.
LEDLIE EM
Clin Radiol; 1960 Apr; 11():130-3. PubMed ID: 14415154
[No Abstract] [Full Text] [Related]
6. Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
Najean Y; Rain JD; Dresch C; Goguel A; Lejeune F; Echard M; Grange MJ
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():111-9. PubMed ID: 8951781
[TBL] [Abstract][Full Text] [Related]
7. Survival in a patient with polycythaemia vera for over thirty years: implications for treatment decisions in younger patients.
Samuelsson J
Leuk Lymphoma; 1998 Dec; 32(1-2):195-8. PubMed ID: 10037017
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
[TBL] [Abstract][Full Text] [Related]
9. The use of 32 phosphorus (32P) in the treatment of polycythemia vera.
Parmentier C; Gardet P
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140
[TBL] [Abstract][Full Text] [Related]
10. Radionuclide therapy of hematologic disorders.
Silberstein EB
Semin Nucl Med; 1979 Apr; 9(2):100-7. PubMed ID: 482947
[TBL] [Abstract][Full Text] [Related]
11. [Radioactive phosphorus (32P); an old, but not bad treatment in polycythemia vera].
Michiels JJ; van Genderen PJ
Ned Tijdschr Geneeskd; 1997 Jan; 141(3):168-9. PubMed ID: 9053768
[No Abstract] [Full Text] [Related]
12. [Polycythemia vera and its treatment with radioactive phosphorus (32P)].
Antić M
Vojnosanit Pregl; 1984; 41(6):451-63. PubMed ID: 6523775
[No Abstract] [Full Text] [Related]
13. [Fate of polycythemia vera treated by radioactive phosphorus. Apropos of a series of 303 patients followed for 12 to 24 years].
Tubiana M; Attie E; Parmentier C
Nouv Presse Med; 1975 Jun; 4(24):1781-6. PubMed ID: 1161478
[TBL] [Abstract][Full Text] [Related]
14. (32)P in the treatment of myeloproliferative disorders.
Lawless S; McMullin MF; Cuthbert R; Houston R
Ulster Med J; 2016 May; 85(2):83-5. PubMed ID: 27601760
[TBL] [Abstract][Full Text] [Related]
15. [Previous results in the treatment of polycythemia vera with a radioactive phosphorus isotope P32].
KRASNIK W; GEMBICKI M; MAGAS S
Pol Tyg Lek; 1961 May; 16():786-9. PubMed ID: 13754006
[No Abstract] [Full Text] [Related]
16. Polycythaemia vera treated with radioactive phosphorus.
FRANK T
Med J Aust; 1952 Feb; 1(7):232-3. PubMed ID: 14918721
[No Abstract] [Full Text] [Related]
17. Multiple myeloma on polycythemia vera following radioactive phosphorus therapy.
West WO
South Med J; 1976 Nov; 69(11):1516-7. PubMed ID: 1019658
[TBL] [Abstract][Full Text] [Related]
18. Busulfan versus 32P in polycythaemia vera.
Zittoun R
Drugs Exp Clin Res; 1986; 12(1-3):283-5. PubMed ID: 3525077
[TBL] [Abstract][Full Text] [Related]
19. Response to radioactive phosphorus treatment of polycythaemia rubra vera in Malaysians: analysis of 8 cases.
Zulkifli A; Chelvam P; Weng Hwa N; Dharmalingam SK
Med J Malaysia; 1979 Jun; 33(4):346-8. PubMed ID: 392273
[No Abstract] [Full Text] [Related]
20. EANM procedure guidelines for 32P therapy.
EANM
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP17-9. PubMed ID: 12723560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
